LEN vs USPH · rev $34.19B vs P/E 34, rev $671.3M
LEN (LEN) versus US Physicalrapy Inc (USPH) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
US Physicalrapy Inc (USPH) is a medical care facilities company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported USPH revenue for 2024-12-31 was $671.3M. Net income was $45.6M. Revenue was up 11.0% from 2023-12-31 to 2024-12-31. USPH currently screens at market cap $1.13B and trailing P/E 34.2.
LEN currently screens at market cap $0. USPH currently screens at market cap $1.13B and trailing P/E 34.2.
Not investment advice. Open the LEN and USPH stock pages for the full models.
Not investment advice.